Cancer Drug and Uses
A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
1 . A pharmaceutical kit comprising a biguanide, a statin, and a benzimidazole.
2 . The pharmaceutical kit according to claim 1 , wherein the biguanide is a metformin, a phenformin, a buformin, or any combination thereof.
3 . The pharmaceutical kit according to claim 1 , wherein the biguanide is a metformin.
4 . The pharmaceutical kit according to claim 1 , wherein the statin is an atorvastatin, a fluvastin, a lovastatin, a pitavastatin, a pravastatin, a rosuvastatin, a simvastatin, or any combination thereof.
5 . The pharmaceutical kit according to claim 1 , wherein the statin is an atorvastatin.
6 . The pharmaceutical kit according to claim 3 , wherein the statin is an atorvastatin.
7 . The pharmaceutical kit according to claim 1 , wherein the benzimidazole is an albendazole, a fenbendazole, a flubendazole, a thiabendazole, a triclabendazole, or any combination thereof.
8 . The pharmaceutical kit according to claim 7 , wherein the flubendazole is a mebendazole.
9 . The pharmaceutical kit according to claim 1 , wherein the benzimidazole is a flubendazole.
10 . The pharmaceutical kit according to claim 9 , wherein the flubendazole is a mebendazole.
11 . The pharmaceutical kit according to claim 6 , wherein the benzimidazole is a mebendazole.
12 . The pharmaceutical kit according to claim 11 , further comprising a doxycycline.
13 . A pharmaceutical kit comprising a biguanide, a statin, and a cytotoxic antibiotic.
14 . The pharmaceutical kit according to claim 13 , wherein the biguanide is a metformin, a phenformin, a buformin, or any combination thereof.
15 . The pharmaceutical kit according to claim 13 , wherein the biguanide is a metformin.
16 . The pharmaceutical kit according to claim 13 , wherein the statin is an atorvastatin, a fluvastin, a lovastatin, a pitavastatin, a pravastatin, a rosuvastatin, a simvastatin, or any combination thereof.
17 . The pharmaceutical kit according to claim 13 , wherein the statin is an atorvastatin.
18 . The pharmaceutical kit according to claim 15 , wherein the statin is an atorvastatin.
19 . The pharmaceutical kit according to claim 13 , wherein the cytotoxic antibiotic is a doxycycline.
20 . The pharmaceutical kit according to claim 18 , wherein the cytotoxic antibiotic is a doxycycline.
21 . The pharmaceutical kit according to claim 20 , further comprising a mebendazole.